TrialThe Journal of dermatology2020

Long-term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis.

Hidemi Nakagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.